XML 13 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents $ 46,408,000 $ 10,288,000
Awards receivable 1,236,000 2,989,000
Prepaid expenses and other current assets 1,055,000 1,718,000
Total current assets 48,699,000 14,995,000
Restricted cash 5,960,000 1,200,000
Property and equipment, net 2,249,000 2,220,000
Operating lease right-of-use asset 35,416,000 35,852,000
In-process research and development 10,256,000 10,256,000
Goodwill 3,490,000 3,490,000
Other assets 1,695,000 1,755,000
Total assets 107,765,000 69,768,000
Current liabilities    
Accounts payable and accrued liabilities 3,437,000 2,270,000
Accrued compensation 1,269,000 1,035,000
Current portion of operating lease liabilities 1,520,000 1,509,000
Total current liabilities 6,226,000 4,814,000
Operating lease liabilities, net of current portion 36,923,000 36,480,000
Deferred tax liability 3,077,000 3,077,000
Total liabilities 46,226,000 44,371,000
Stockholders' equity    
Common stock, $0.01 par value; 217,000,000 shares authorized; 36,112,053 and 27,112,299 shares issued and outstanding at March 31, 2022 and December 31, 2021, respectively 361,000 271,000
Additional paid-in capital 272,809,000 227,983,000
Accumulated deficit (211,631,000) (202,857,000)
Total stockholders' equity 61,539,000 25,397,000
Total liabilities and stockholders' equity $ 107,765,000 $ 69,768,000